Report on Activities for the Quarter ended 31 December 2021 31 January 202228 January 2022 by Audrey Thomson Report on Activities for the Quarter Ended 31 December 2021
Quarterly Report 31 December 2021 31 January 202228 January 2022 by Audrey Thomson Quarterly Report 31 December 2021
Update on Biotron’s HIV-1 and COVID-19 Programs 16 December 2021 by Audrey Thomson Update on Biotron’s HIV-1 and COVID-19 Programs
Biotron Drug Effective Against COVID-19 in Animals 25 November 2021 by Audrey Thomson Biotron Drug Effective Against COVID-19 in Animals
Presentation to Annual General Meeting 23 November 2021 by Audrey Thomson Presentation to Annual General Meeting
Results of Annual General Meeting 23 November 2021 by Audrey Thomson Results of Annual General Meeting
Presentation to Annual General Meeting 23 November 2021 by Audrey Thomson Presentation to Annual General Meeting
Commencement of Two Pivotal BIT225 Clinical Trials 1 November 2021 by Audrey Thomson Commencement of Two Pivotal BIT225 Clinical Trials
Report on Activities for the Quarter ended 30 September 2021 28 October 2021 by Audrey Thomson Report on Activities for the Quarter Ended 30 September 2021